Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Genome Editing for Neurodegenerative Diseases -

Genome Editing for Neurodegenerative Diseases

From Concept to Clinical Trials
Buch | Softcover
260 Seiten
2024
Academic Press Inc (Verlag)
9780443238260 (ISBN)
CHF 279,95 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Genome Editing for Neurodegenerative Diseases: From Concept to Clinical Trials examines recent advances in neurodegenerative disease research and clinical challenges in practical applications. With an emphasis on genome editing tools such as ZFNs, TALENSs and CRISPR-Cas, this book sheds light on the possibilities to counteract genetic and neurodegenerative diseases. It will be of interest to researchers in neuroscience and biopharmaceuticals, as well as clinicians specializing in neurodegenerative diseases.

Dr. Sandeep Kumar Singh holds a PhD in Biotechnology and is an Assistant Professor of Medical Biotechnology at the All India Institute of Medical Sciences (AIIMS), Nagpur, Maharashtra, India. With nearly a decade of research experience, including a postdoctoral tenure in the Department of Neurobiology at The University of Chicago, his expertise spans molecular and cellular neuroscience. Dr. Amarish K Yadav is a postdoctoral research scholar at North Carolina State University. His current research interest is developing gene-drive systems using CRISPR/Cas9 in Drosophila suzukii. After obtaining his master’s degree in biotechnology, he was awarded his Ph.D. from Banaras Hindu University in 2017. He has worked in collaboration with many neuroscientists and researchers to understand the molecular mechanisms of Alzheimer’s and Parkinson’s diseases progression and therapeutics. Dr. Yadav has published his research findings in peer-reviewed journals and has also authored a book chapter on neurodegenerative diseases modeling in drosophila. Dr. Yadav has participated and presented his research work at various national and international conferences and symposia. Dr. Burkhard Poeggeler (Georg-August-University of Göttingen, Germany) holds a PhD in Biochemistry and has authored over 120 PubMed-indexed publications. His research focuses on neuroprotection, redox biology, and regenerative pharmacology. Dr. George Perry, Ph.D. Professor of Biology and Chemistry Semmes Foundation Distinguished University Chair in Neurobiology He is a neuroscientist known for his work on neuronal oxidation of nucleic acids in Alzheimer's disease. He is distinguished as one of the top Alzheimer’s disease researchers with over 1000 publications, won numerous awards, and is one of the top 100 most-cited scientists.

Introduction
Burkhard Poeggeler
1. Therapeutic potential of genome editing tools in neurodegenerative diseases
Ankur Kumar, Nandigam Pardhipa, Sachin G. Swami, Vibha Dwivedi and Anand K. Singh
2. Genetic and molecular basis of neurodegenerative diseases
Sunanda Yogi, Anjali Sangeeth, Anuradha Venkatakrishnan Chimata, Radhika Padma and Amit Singh
3. Genome editing tools: principles, structures, and mechanisms
Rayees Ahmad Naik, Mehak Naseer Mir, Roshni Rajpoot, Sonalika Singh, Kusum Singh and Sandeep Kumar Singh
4. Advances in CRISPER/Cas system and genome editing technologies for the treatment of neurodegenerative diseases
Shailendra Kumar Mishra, Hung-Ming Chang, Ahmad A. Obaid and Sandeep Kumar Singh
5. Use of CRISPR system in genetic screening to detect neurodegenerative disease
Koyel Kar
6. Epigenetic manipulation and gene regulation using the CRISPR/Cas system for neurodegenerative diseases
Josephine Esposto
7. Transgene delivery system: viral, nonviral, and other methods for central nervous system
Bhupender Sahu, Bibhudendu Behera and Umesh Kumar
8. Gene therapies for neurodegenerative disease: current knowledge and challenges
Bhumi Arora, Sakshi Garg, Aditya Shrivastav, Mrinalini Sharma, Bhupender Sahu and Umesh Kumar
9. Gene therapy under clinical trials for neurodegenerative diseases
Bhupender Sahu, Lakshita Tyagi, Prshant Tyagi and Umesh Kumar
10. Clinical challenges and future prospective in use of gene-editing tools as neurotherapeutics
Burkhard Poeggeler

Erscheinungsdatum
Verlagsort San Diego
Sprache englisch
Maße 152 x 229 mm
Gewicht 420 g
Themenwelt Geisteswissenschaften Psychologie Entwicklungspsychologie
Naturwissenschaften Biologie Humanbiologie
Naturwissenschaften Biologie Zoologie
ISBN-13 9780443238260 / 9780443238260
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Vormals Oerter & Montada

von Wolfgang Schneider; Ulman Lindenberger

Buch | Hardcover (2018)
Julius Beltz GmbH & Co. KG (Verlag)
CHF 89,60
entwicklungspsychiatrische, sexual- und kulturwissenschaftliche …

von Alexander Korte

Buch | Hardcover (2024)
Kohlhammer (Verlag)
CHF 37,80